Recent discussions on X about Sotera Health Company (SHC) have centered around the company's announcement of a secondary offering of 20 million shares by affiliates of major investment firms. Many users have expressed concern over the potential dilution of stock value following this move, with some speculating about the impact on short-term price movements. The conversation has been lively, as investors weigh the implications of this offering against the company's reported 6.4% revenue growth in the healthcare sector.
Additionally, there is a mix of perspectives on X regarding SHC's long-term prospects, with some highlighting the company's strategic position in healthcare services as a positive factor. Others, however, have pointed to the recent 3.9% drop in share price as a sign of market skepticism following the offering news. The dialogue remains dynamic, reflecting broader uncertainties in the sector.
Note: This discussion summary was generated from an AI condensation of post data.
Sotera Health Company Insider Trading Activity
Sotera Health Company insiders have traded $SHC stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SHC stock by insiders over the last 6 months:
- PINCUS & CO. WARBURG has made 0 purchases and 2 sales selling 24,000,000 shares for an estimated $362,664,000.
- INVESTMENT XI LLC GTCR sold 8,000,000 shares for an estimated $120,888,000
- MICHAEL P RUTZ (President of Sterigenics) sold 126,611 shares for an estimated $2,074,305
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Sotera Health Company Hedge Fund Activity
We have seen 149 institutional investors add shares of Sotera Health Company stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TPG GP A, LLC removed 6,786,110 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $75,461,543
- SCULPTOR CAPITAL LP added 2,462,489 shares (+27.2%) to their portfolio in Q2 2025, for an estimated $27,382,877
- ARROWMARK COLORADO HOLDINGS LLC removed 1,867,829 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,770,258
- POINT72 (DIFC) LTD added 1,136,326 shares (+192.6%) to their portfolio in Q2 2025, for an estimated $12,635,945
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,101,604 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,249,836
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,007,963 shares (+12.5%) to their portfolio in Q2 2025, for an estimated $11,208,548
- KHROM CAPITAL MANAGEMENT LLC added 988,801 shares (+174.1%) to their portfolio in Q2 2025, for an estimated $10,995,467
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Sotera Health Company Analyst Ratings
Wall Street analysts have issued reports on $SHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/24/2025
- Goldman Sachs issued a "Buy" rating on 05/05/2025
To track analyst ratings and price targets for Sotera Health Company, check out Quiver Quantitative's $SHC forecast page.
Sotera Health Company Price Targets
Multiple analysts have issued price targets for $SHC recently. We have seen 3 analysts offer price targets for $SHC in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $13.0 on 06/24/2025
- Matthew Sykes from Goldman Sachs set a target price of $17.0 on 05/05/2025
- Jason Bednar from Piper Sandler set a target price of $13.0 on 04/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
